For Merck, bringing cattle feed Zilmax back won’t be easy
P.J. Huffstutter and Lisa Baertlein
Reuters
U.S. pharmaceutical giant Merck & Co (MRK.N) faces significant challenges bringing its controversial feed additive Zilmax back to market in the United States and Canada, even after a vote of confidence from South Korea on Thursday.